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The  aim of the  present  study  was  to assess  the  activity  of the  hazelnut  oil  in  the  treatment  of  poly-
cystic  ovary  syndrome  in  rats.  Serum  follicle-stimulating  hormone,  luteinizing  hormone,  estradiol,
progesterone,  testosterone,  serum  lipid  parameters,  leptin  and  glucose  levels  were  evaluated.  Moreover,
antioxidant  activity  was  tested  using  superoxide  dismutase,  malondialdehyde,  catalase,  glutathione  per-
oxidase levels.  The  phytosterol  content  of  the oil was  determined  by  HPLC.  The  plasma  high  density
lipoprotein-cholesterol  level  was  found  to be signiﬁcantly  high  and  leptin  and  glucose  concentrations
were  found  to be signiﬁcantly  low  in the treatment  group.  According  to  the  phytochemical  analysis,  theorylus avellana
hytosterol
etrozole
olycystic ovary syndrome
ntioxidant
main components  of  the  oil were detected  as  -tocopherol,  -tocopherol,  squalene,  -sitosterol,  campes-
terol  and  stigmasterol.  Corylus  avellana  oil  was  found  to  be effective  in  the  treatment  of polycystic  ovary
syndrome  via  regulating  gonadotropins,  steroids  and  serum  lipid  parameters  and  possesses  antioxidant
activity.
ileira© 2015 Sociedade  Bras
ntroduction
Polycystic ovary syndrome (PCOS) is a common endocrine disor-
er which causes anovulation in animal and women  of reproductive
ge (Dehghan et al., 2012; Zhai et al., 2012; Arikawe et al., 2013).
ts hyperandrogenic manifestations include menstrual irregularity,
cne, hirsutism and oligo-ovulation/anovulation. Metabolic abnor-
alities such as dyslipidemia, insulin resistance, therefore, diseases
ncluding diabetes, obesity, cancer and infertility as well as coro-
ary heart diseases could be seen along with PCOS (Maharjan et al.,
010; Zhai et al., 2012; Ghasemzadeh et al., 2013).
PCOS is characterized by small arrested antral follicle formation
n the development process. In PCOS estrogen level decreases, how-
ver, the progesterone level increases and LH/FSH ratio becomes
hree times of the normal level. Androgens are synthesized by the
heca cells (Walters et al., 2012).
Corylus avellana L., Betulaceae, is growing wild in Europa, West-
rn Asia and Northern Africa as large shrubs or small trees about
.5–4.5 m high. The leaves are deciduous, rounded, 6–12 cm long,
oftly hairy on both surfaces, with a double-serrate margin. The
owers are monoecious, with single-sex catkins, the male pale
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E-mail: esrak@gazi.edu.tr (E. Kupeli Akkol).
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yellow and 5–12 cm long. The edible part of the hazelnut is the
roughly spherical seed, which is covered by a dark brown perisperm
and protected by a hard, woody shell. The ripening nut is enclosed
in a green fringed tube (Könemann, 1999; Contini et al., 2011).
This plant was  reported to contain vitamins including vitamin E,
B6 and B9, unsaturated fatty acids, plant sterols and polyphenols
(Jakopic et al., 2011). One of the most important features of C.
avellana is to have the highest ratio of unsaturated/saturated fatty
acids. Moreover, C. avellana was shown to reduce plasma total
and LDL cholesterol concentrations, by its polyunsaturated fatty
acid, phytosterol and soluble dietary ﬁber content (Weststrate and
Meijer, 1998; Brown et al., 1999; Feldman, 2002). A high ﬁber
diet can be beneﬁcial for the health of heart and digestive sys-
tem and can help to regulate the blood glucose level (Anderson
et al., 2009). C. avellana is a poor source of isoﬂavones, indeed,
seed oil contains only trace amounts of phytoestrogens (Mazur,
2000).
According to the data reported in ethnobotanical studies, C. avel-
lana has been used for the treatment of varicose veins, hemorrhoids,
diabetes mellitus and gynecological disorders (Sezik et al., 1997;
Ramalhosai et al., 2011; Abeer and Amr, 2013). The aim of the
present study was to evaluate the activity potential of C. avellana
oil in the treatment of PCOS and analyze the phytochemical con-
stituents by using chromatographic methods in order to ﬁnd out
the compounds responsible from the efﬁcacy.
 Ltda. All rights reserved.
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aterials and methods
lant material
Seeds of Corylus avellana L., Betulaceae, were collected from Tra-
zon, Akc¸ abat village, Turkey in August 2013. A voucher specimen
as deposited in the Herbarium of Faculty of Pharmacy, Gazi Uni-
ersity, Ankara, Turkey.
reparation of the oil
The plant material (50 g) was air dried and grinded. Ground
azelnut was weighed (10 g) and the oil was extracted with
exane in a Soxhlet apparatus during 6 h (James, 1995). The
xtract was evaporated at 40 ◦C. The oil content of the hazel-
ut was determined to be 51.23%. The oil was kept in a
ark bottle in a freezer at −25 ◦C until the time of analy-
is.
aponiﬁcation of sterol, tocopherol and squalene for HPLC analysis
The oil (30 mg)  was mixed thoroughly with 50% KOH (w/v)
200 l) and 1% ethanolic pyrogallol (w/v) (1.5 ml). The tubes
ere kept at 70 ◦C in a water bath for 40 min. Water (0.5 ml)
nd hexane (3 ml)  were added to the tubes after cooling on ice.
he tubes were shaken and centrifuged at 400 × g for 10 min.
he hexane phase was removed and the extraction repeated with
exane (1 ml). The combined hexane extracts were dried and
as redissolved in ethanol (150 l) and transferred into an HPLC
ial.
nalyses of phytosterols, squalene and tocopherols by HPLC
HPLC conditions on Varian a ProStar HPLC system include Var-
an ProStar 240 Pump, Varian ProStar 410 AutoSampler, Varian
roStar 510 Column Oven, Varian ProStar 335 UV/VIS Detector.
ample (10 l) was injected onto a Phenomenex luna C8 5u Sil-
ca 100A (150 mm × 4.6 mm LC Column) for phytosterol analysis.
he chromatographic separation of the sample was  performed
sing a mobile phase consisting of 80% acetonitrile and 20% water
t a ﬂow rate of 1.5 ml/min. For the analyses of tocopherol and
qualene, Supelcosil LC-18 Column, 3 m,  (4.6 mm × 150 mm i.d.;
upelco, Bellefonte, PA, USA) and mobile phase consisting of 99%
ethanol and 1% water was used at a ﬂow rate of 1.3 ml/min.
eak areas were recorded using Galaxie Chromatography Worksta-
ion software version 1.9.3.2 (Varian, Inc. Marketing Department
700 Mitchell Drive Walnut Creek, CA 94598). Chromatograms
ere extracted at 205 nm,  292 nm and 215 nm for phytosterol,
ocopherol and squalene analysis respectively (Maguire et al.,
004).
nimals
Eleven-week-old female, non-pregnant, eighteen mature
prague Dawley rats (200–250 g) with 4–5 days regular estrus
ycles were used in the study. All rats were purchased from Kobay
xperimental Animals Laboratory, Ankara, Turkey and quarantined
or at least two weeks. The animals were housed in polysulfone
ages at 21–24 ◦C, 40–45% humidity, and light and dark cycles of
2 h conditions at Laboratory Animals Breeding and Experimental
esearches Center, Faculty of Pharmacy, Gazi University, Ankara,
urkey. The experiments were conducted in accordance with the
irections of Guide for the Care and Use of Laboratory Animals.
he experiment was approved by the Experimental Animal Ethics
ommittee of Gazi University (G.Ü. E.T-14-022). Farmacognosia 26 (2016) 83–88
Experimental design
Letrozole (Letrasan®, DevaHolding A.S., Tekirdag, Turkey)
(concentration of 1 mg/kg) was  dissolved in 0.5% carboxymethyl-
cellulose (CMC) was administered to the rats by gavage once daily
throughout 21 days. This dose was  chosen according to the pre-
vious studies in which the cystic follicle formation was  induced
(Rezvanfar et al., 2012a). During the experiment, the estrus cycle
was microscopically evaluated by the analyses of relative pro-
portion of leukocytes, epithelial and corniﬁed cells. Body weight
change due to the administration of letrozole was  weekly observed.
All rats were randomly divided into following three groups consist-
ing of six rats in each group: (i) control group (CMC; 2 ml/rat/day,
p.o.), (ii) reference group (buserelin acetate; 20 mg/rat/week, s.c.)
and (iii) treatment group (C. avellana; 2 ml/rat/day, p.o.). The test
materials were administered throughout 45 days.
Termination of the procedure
The animals were euthanized 24 h after the last dose of the treat-
ment. Blood samples were collected by cardiac puncture. Serum
was separated and kept in a freezer at −20 ◦C for determination FSH,
LH, estradiol, progesterone, testosterone, TC, HDL-C, LDL-C, TGs,
leptin and glucose, SOD, MDA, catalase, GPx levels. Uteri and ovaries
were dissected, and weighed for the evaluation of the endocrine
function.
Measurement of circulating levels of serum gonadotropins and
steroids
Serum gonadotropin levels were determined using radioim-
munoassay (RIA). All RIA kits were obtained according to the
manufacturer’s instruction from Beckman Coulter Co., Marseille,
France. Serum FSH was  assayed by sandwich RIA using a com-
mercially available RIA kit. Serum LH, estradiol, progesterone, and
testosterone were measured by competition radioimmunoassay
with commercially available RIA kits.
Evaluation of the blood lipid, leptin and glucose levels
Plasma leptin (Cat. EZRL-83K) concentration was determined by
ELISA using a rat kit (Linco Research, Inc., St. Charles, USA). Plasma
triacylglyceride, total cholesterol, HDL-C LDL-C values were mea-
sured with commercially available assay kits (Human Diagnostica.
GmbH, Germany). Blood glucose level was determined using Glu-
cose Roche Diagnostic glucometer strip.
Determination of antioxidant activity
SOD, GPx, MDA, catalase levels were analyzed for the determi-
nation of the antioxidant activity potential. SOD and GPx activities
were measured as described in Rezvanfar et al. (2012b). SOD assay
was evaluated by the rate of increase at 560 nm.  GPx activity
was read by the determination of the decrease in absorbance at
365 nm.  MDA  level and catalase activity were studied biochemi-
cally in erythrocyte lysate samples. Catalase activity was measured
and calculated according to Aebi’s method by recording the hydro-
gen peroxide degradation spectrophotometrically at 240 nm (Aebi,
1984). MDA  was  measured by the modiﬁed Yagi (1984).
HistologyThe specimens were ﬁxed in 10% buffered formalin, processed,
and embedded in parafﬁn and sectioned 5 m thicknesses. These
sections were stained with hematoxylin-eosin (HE). Pathological-
physiological structures in ovaries were classiﬁed on the HE stained
M.A. Demirel et al. / Revista Brasileira de Farmacognosia 26 (2016) 83–88 85
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Fig. 2. Histopathological view of the experimental groups. The images are presentedFig. 1. Wiev of the vaginal cytology in control (A) and treatment (B) groups.
ections with a light microscope and Kameram® image analysis
ystem (Microsystem, Istanbul, Turkey).
tatistical analysis
Statistical analysis was performed using SPSS version 16. The
esults were expressed as the Mean ± S.D. Dunnett’s test was  used
o determine the signiﬁcance of differences between groups. In
rder to compare two groups Student’s t test was  used. A probability
alue <0.05 was considered statistically signiﬁcant.
esults
The levels of total -tocopherol and gama-tocopherol was calcu-
ated as 301.5 g/g and 52.8 g/g, respectively. 173.7 g/g squalene
as detected in the nut. The levels of phytosterols were detected
s follows; -sitosterol 875.4 g/g; campesterol 75.4 g/g and stig-
asterol 44.9 g/g.
After letrozole administration to the rats, reproductive cycle
as found to be irregular. Following the administration of test
aterials, the control group displayed irregular estrous cycles and
xhibited constant estrus (Fig. 1A), whereas the treatment group
nd the reference group exhibited regular estrous cycles (Fig. 1B).
Twenty one days after the letrozole administration, all rats
xhibited signiﬁcant increase in the body weight (control group:
84.5 ± 12.5 g, treatment group: 384.7 ± 13.0 g and reference
roup: 386.8 ± 12.7 g). After the treatment with hazelnut oil and
he reference drug buserelin, a remarkable decrease was observed
n the body weight which was detected as 304.7 ± 11.0 g and
08.2 ± 12.1 g, respectively. However, the body weight of the con-
rol group animals increased to 424.6 ± 10.6 g.were stained with HxE. The original magniﬁcation was 1.25× and the scale bars
represent 1000 m.  (A) Control group; (B) treatment group; (C) reference group.
Abbreviations as shown on the images; cl: corpus luteum, cf: cystic follicle.
In comparison with the control group, hazelnut oil and the
reference drug administration caused remission in the ovar-
ian weight at the end of the experiment (25.6 ± 1.2 mg/100 g,
21 ± 1.0 mg/100 g and 22 ± 1.2 mg/100 g, (p < 0.05) respectively).
However, after the administration of hazelnut oil and the ref-
erence drug the uterine weight was  increased when compared
to control group (88.2 ± 1.2 mg/100 g, 92.0 ± 1.4 mg/100 g and
51 ± 1.1 mg/100 g, (p < 0.05) respectively).
Follicular cysts, seconder follicles and atretic follicles were
recorded as severe in the control group, moderate in the treatment
group, and mild in the reference group. Lumen of follicular cysts
was bordered with single or more layered granulosa cells. Degener-
ation and desquamation of these cells and thickened theca interna
were severe in the control group. Compared to the other groups
regression of corpus luteum was  prominent in the reference group,
moderate in the treatment group and mild in the control group
(Fig. 2).
High FSH and LH levels were detected in the control group, while
the treatment and reference groups’ levels were found to be nor-
mal. Furthermore, testosterone levels signiﬁcantly augmented in
the control group, indicating the hyperandrogenism. Estradiol and
progesteron levels decreased in the control group when compared
86 M.A. Demirel et al. / Revista Brasileira de Farmacognosia 26 (2016) 83–88
Table 1
Serum gonadotropin and steroid levels in control, treatment and reference groups.
Groups FSH (ng/ml) LH (ng/ml) Estradiol (pg/ml) Progesterone (ng/ml) Testosteron (ng/dl)
Control 108.3 ± 5.8 8.7 ± 1.6 2.6 ± 0.3 9.85 ± 1.7 267.46 ± 23.5
Treatment 87.6 ± 3.2 2.8 ± 0.2*** 9.06 ± 1.3** 26.8 ± 1.5*** 92.4 ± 7.3***
Reference 75.2 ± 7.5* 3.6 ± 0.4*** 10.8 ± 1.9** 36.4 ± 5.2** 72.64 ± 6.2***
* p < 0.05.
** p < 0.01.
*** p < 0.001 (treatment and reference groups were compared with the control group).
Data presented as Statistical Mean ± Standard Deviation (SD).
Table 2
Effects of Corylus avellana on plasma concentrations of TC, TG, HDL-C, LDL-C, leptin and glucose.
Groups TC (mg/dl) TG (mg/dl) HDL-C (mg/dl) LDL-C (mg/dl) Leptin (g/l) Glucose (mg/dl)
Control 52.01 ± 4.11 114.81 ± 10.24 53.59 ± 5.72 19.61 ± 6.38 5.94 ± 1.79 136.45 ± 10.93
Treatment 41.58 ± 3.18 102.55 ± 11.93 78.36 ± 3.15** 15.50 ± 4.19 3.98 ± 1.04* 107.74 ± 3.41*
Reference 31.46 ± 1.09* 84.72 ± 9.08* 85.32 ± 2.10** 12.48 ± 3.07* 2.46 ± 1.12** 98.06 ± 2.22**
* p < 0.05.
** p < 0.01 (treatment and reference groups were compared with the control group).
Data presented as Statistical Mean ± Standard Deviation (SD).
Table 3
Serum levels of MDA, SOD, catalase and GPx levels in all groups.
Groups MDA  (mmol/ml) SOD (u/mg protein) Catalase (mmol/ml) GPx (u/mg protein)
Control 3.41 ± 0.58 846.12 ± 20.03 7.46 ± 2.32 112.42 ± 9.52
Treatment 2.63 ± 0.21* 994.05 ± 17.22 9.24 ± 1.62* 107.25 ± 5.27
Reference 1.24 ± 0.14** 1032.26 ± 25.47* 8.43 ± 1.89 104.71 ± 6.13
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** p < 0.01 (treatment and reference groups were compared with the control grou
ata presented as Statistical Mean ± Standard Deviation (SD).
o the treatment and reference groups. While estradiol (p < 0.01)
nd progesterone (p < 0.001) levels signiﬁcantly increased, LH and
estosteron (p < 0.001) levels decreased in the treatment group
hen compared to the control group (Table 1). However this
ifference was not signiﬁcant between the reference group and
reatment group.
Serum TC, TG, HDL-C, LDL-C, leptin and glucose lev-
ls were respectively 41.58 ± 3.18 mg/dl, 102.55 ± 11.93 mg/dl,
8.36 ± 3.15 mg/dl, 15.50 ± 4.19 mg/dl, 3.98 ± 1.04 g/l, 107.74 ±
.41 mg/dl in the treatment group. The plasma HDL-C (p < 0.01),
eptin and glucose (p < 0.001) concentrations were found to be sig-
iﬁcant in the treatment group when compared to the control
roup (Table 2).
Serum MDA, SOD, catalase and GPx levels were deter-
ined as 2.63 ± 0.21 mmol/ml, 994.05 ± 17.22 u/mg protein,
.24 ± 1.62 mmol/ml  and 107.25 ± 5.27 u/mg protein, respectively
n the treatment group. Serum catalase (p < 0.05) levels signiﬁ-
antly increased in the treatment group when compared to the
ontrol group. There was no statistically signiﬁcant difference
etween the treatment and reference groups in terms of the
ntioxidant activity (p > 0.05) (Table 3).
For the acute toxicity evaluation, the oil was administered orally
o the rats at 1, 2 and 4 ml/rat/day doses. The animals were observed
or 48 h and neither toxicity nor mortality was recorded.
iscussion
There are several hypotheses on the etiology of PCOS, which
s a common endocrine disorder in women and animals, however,
here is limited information regarding the mechanisms of its devel-
pment (Ball and Peters, 2004; Padmanabhan and Veiga-Lopez,
013). Treatment of PCOS is highly important for the economi-
ally valuable animals such as livestock (Ball and Peters, 2004).
he therapeutic approaches to PCOS are mainly symptomatic sincelittle information is available on the etiopathogenesis of the dis-
ease. Some pharmacological agents such as oral contraceptives,
antiandrogens, GnRH agonists, steroids, insulin sensitizers such as
metformin, troglitazone are preferred both for human and animal
in the treatment of PCOS (Dehghan et al., 2012). However, due to the
adverse effects caused by synthetic drugs, the plant based remedies
are much preferable in the treatment of PCOS.
Previous studies on the family Betulaceae revealed that the
plants are rich in the phenolic constituents including ﬂavonoids,
tannins, caffeic acid derivatives, diarylheptanoid-type compounds
(Jin et al., 2007; Martineau et al., 2010). Diarylheptanoids were
found to possess various pharmacological effects such as anti-
inﬂammatory, antioxidant, anticancer and antiadipogenic activities
(Jin et al., 2007; Martineau et al., 2010). Moreover, diarylheptanoids
are the major components, which exhibit high estrogenic activity
by ASPP 049 mediated transcriptional activation through a ligand-
dependent ER-estrogen-responsive element-driven pathway and
a non-genomic action on vascular relaxation through the ER-Akt-
endothelium nitric oxide synthase pathway (Suksamrarn et al.,
2008; Winuthayanon et al., 2009a,b; Intapad et al., 2009).
A number of reports have suggested that phytosterols possess
estrogenic activity and therefore, have potential effects on the
reproductive system. According to the previous published articles
especially -sitosterol was  found to act as an estrogenic agent
(Malini and Vanithakumari, 1992; Mellanen et al., 1996). Although
the estrogenic potential of -sitosterol was  conﬁrmed by several
in vitro and in vivo experiments, a mechanistic study suggested that
-sitosterol is not estrogenic itself but needs to be metabolized to
a hormonally active metabolite (Mellanen et al., 1996).
According to the HPLC analysis, campesterol, stigmasterol, -
sitosterol, squelene and tocopherol were determined in hazelnut
oil in the present study. These results were found to be in accord
with the previous studies (Parcerisa et al., 1998; Baker et al.,
1999).
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Alteration in the oxidant-antioxidant proﬁle is known to occur
n polycystic ovary syndrome (Verit and Erel, 2008). Reactive
xygen species cause the formation of lipid hydroperoxides, con-
ugated dienes, and MDA, as well oxidize biomolecules leading to
xtensive lipid peroxidation (LPO) in proteins, membranes, and
enes (Kucukkurt et al., 2008). The evaluation of MDA  is an indicator
f free-radical damage through membrane LPO (Keles et al., 2012).
n the present study, blood MDA  level decreased in the treatment
roup when compared to control group which suggest hazelnut
nclude active components against LPO. Antioxidants involve enzy-
atic systems such as SOD, glutathione peroxidase, and CAT which
revent the oxidative cell injury on tissues (Kyle et al., 1987).
OD protects the tissues from the harmful effects of superoxide
adicals and CAT enzyme hydrolyzes H2O2 into H2O and 1/2 O2.
hese enzymes have an important role in the resistance of cellular
ipids, proteins, and DNA (Matés and Sánchez-Jiménez, 1999). In
he present study, the levels of erythrocyte SOD and CAT activities
ncreased whereas GPx level decreased when compared to control
roup.
The ethanolic extract of C. avellana seed displayed remarkable
ntioxidant activity in total antioxidant and radical scaveng-
ng tests, which could be attributed to the relatively high
otal phenol content of the extract (Shahidi et al., 2007).
yricetin-3-O-rhamnoside, quercetin-3-O-rhamnoside, gallic acid,
rotocatechuic acid, phloretin-2′-O-glucoside, (+)-catechin, (−)-
picatechin and procyanidins were reported as the major phenolic
ompounds of C. avellana seed (Weststrate and Meijer, 1998).
Phytosterols such as squalene, campesterol, -sitosterol, stig-
asterol, tocopherol have been determined as the potential
ntioxidant agents in the previous studies (Smith, 2000; Kmiecik
t al., 2011; de Franc¸ a Ferreira et al., 2014). Therefore, it was sug-
ested that phytosterols determined herein, probably promoted
he treatment of PCOS by their antioxidant effect.
Insulin plays an important role in the modulation of blood FSH
evels (Sudha et al., 2000). The antioxidant activity of C. avellana
ould be responsible from the regulator effect of gonadal hormone
evels in rats with high level glucose due to PCOS as a reproduc-
ive problem. Therefore, the improvement in the blood glucose and
erum insulin levels could be associated with the improvement in
he serum FSH and LH hormones.
The main components of the oil were detected as -tocopherol,
-tocopherol, squalene, -sitosterol, campesterol and stigmasterol.
. avellana oil was found to be effective in the treatment of PCOS
ia regulating gonadotropins, steroids and serum lipid parameters
nd possess antioxidant activity.
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